IDR1004-ABT-888(Veliparib)
ABT-888(Veliparib),>99%
【英文同义名】:Veliparib, ABT-888, ABT888, ABT 888, NSC737664, NSC 737664, NSC-737664
【中文同义名】:
订购信息:(原装进口,常备现货)
品 Pai | 产品名称 | 产品货号 | 规 格 | 目录价(元) |
Gene Operation | ABT-888(Veliparib) | IDR1004-0005MG | 5 mg | ¥599.00 |
IDR1004-0010MG | 10 mg | ¥979.00 |
IDR1004-0050MG | 50 mg | ¥2,989.00 |
产品描述ABT-888(veliparib)是一种GX的,可口服的PARP-1 和 PARP-2YZ剂,其IC50别为5.2 和 2.9 nmol/L,且还能YZSIRT2 [1]。ABT-888能增强如化疗和放疗等DNA损伤剂的作用。体内外实验表明本品具有显著的YZPARP活性的作用。文献报道,在C41 [2]和H460 [3]细胞中,ABT-888YZPARP活性。在ZL转移性乳腺癌、结肠癌、转移性黑色素瘤和脑肿瘤方面已取得显著的效果,其与替莫唑胺联用ZL乳腺癌的研究已经进入临床III期。
靶点
靶点 | PARP-1 | PARP-2 |
Kis(YZ常数) | 5.2 nM | 2.9 nM |
化学特性
Cas No.: 912444-00-9 | M. Wt.: 244.3 | Formula: C13H16N4O | Purity: >99% | Synonym: Veliparib, ABT-888, ABT888, ABT 888,, NSC737664, NSC 737664, NSC-737664 | Chemical Name: 2-[(2R)-2-Methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide . dihydrochloride | Appearance: powder | Solubility: Soluble in DMSO (up to 25 mM) (参考selleck,merck,sigma) | Storage:Store powder at -20 ºC for the stability of two years(selleck -20 ºC) |
| |
储存液配制储存液 (1 ml DMSO体系) | 1 mM | 5 mM | 10 mM | 25 mM | 50 mM |
质量(mg) | 0.2443 | 1.2215 | 2.443 | 6.1075 | 12.215 |
结构式
使用浓度(仅作参考)ABT-888(Veliparib)的具体使用浓度请参考相关文献,并根据自身实验条件(如实验目的,细胞种类,培养特性等)进行摸索和优化。
参考文献[1] Cherrie K. Donawho, et al. ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models. Clin Cancer Res, 13 (9), 2728-2737 (2007). [2] Penning TD, et al. Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer.J Med Chem. 52(2):514-23 (2009). [3] Albert JM, et al. Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models.Clin Cancer Res. 13(10):3033-42 (2007).